Nick Train: UK market is ‘pregnant with value and opportunity’
Finsbury Growth & Income manager says the ‘breaks are running’ against his portfolio currently
In this week’s Head-to-Head, Gavin Haynes, managing director at Whitechurch Securities, matches up two medical heavyweights – Axa Framlington Biotech and Polar Capital Healthcare Opportunities.
MORE ARTICLES ON
Finsbury Growth & Income manager says the ‘breaks are running’ against his portfolio currently
‘Governments, and their agents such as central banks, are very much involved in controlling economies and financial markets’
Sophia Sednaoui and Katie Forbes to join investor relations team
Aegon’s Komulainen has called on fund managers to vote against climate transition plans at Shell’s AGM
JP Morgan US Equity Income and Hermes Global Emerging Markets funds switched for BNY Mellon and Baillie Gifford offerings
Invesco Bond Income Plus Limited trust given Elite rating